OncoPro Hereditary Cancer Risk Panel – Comprehensive 200 Gene Screening
Understanding Hereditary Cancer Risk Assessment
The OncoPro Hereditary Cancer Risk Panel represents a groundbreaking advancement in genetic cancer screening, offering comprehensive analysis of 200 genes linked to inherited cancer predisposition. This sophisticated molecular diagnostic test utilizes cutting-edge Next Generation Sequencing technology to identify genetic mutations that significantly elevate an individual’s lifetime cancer risk. Understanding your genetic predisposition empowers proactive healthcare decisions and personalized prevention strategies.
What the Test Measures and Detects
This comprehensive panel screens for mutations across a wide spectrum of cancer-associated genes, including:
- BRCA1 and BRCA2 – Associated with breast, ovarian, and prostate cancers
- TP53 – Li-Fraumeni syndrome related cancers
- MLH1, MSH2, MSH6, PMS2 – Lynch syndrome genes
- APC – Familial adenomatous polyposis
- PTEN – Cowden syndrome
- STK11 – Peutz-Jeghers syndrome
- CDH1 – Hereditary diffuse gastric cancer
- VHL – Von Hippel-Lindau syndrome
- RET – Multiple endocrine neoplasia
Who Should Consider This Genetic Cancer Screening
Individuals with These Risk Factors:
- Personal history of cancer diagnosed at young age (under 50)
- Multiple primary cancers in the same individual
- Family history of multiple cancer types across generations
- Known genetic mutation in family members
- Rare cancers or unusual cancer patterns in family
- Ashkenazi Jewish ancestry with cancer history
- Multiple polyps in colon or other organs
- Bilateral cancer in paired organs
Comprehensive Benefits of Genetic Cancer Testing
Proactive Health Management
Early identification of genetic cancer risk enables personalized surveillance plans, including more frequent screenings and specialized imaging protocols tailored to your specific risk profile.
Family Risk Assessment
Positive results provide valuable information for family members, allowing them to pursue targeted testing and implement preventive measures if necessary.
Treatment Guidance
For individuals with existing cancer diagnoses, genetic information can influence treatment decisions and help identify targeted therapies.
Reproductive Planning
Couples can make informed decisions about family planning when hereditary cancer risks are identified.
Understanding Your Test Results
Possible Outcomes and Their Meanings
- Positive Result: A pathogenic mutation was identified in one or more cancer-associated genes. This indicates an increased cancer risk, and our genetic counselors will provide detailed guidance on next steps, surveillance recommendations, and family testing considerations.
- Negative Result: No known pathogenic mutations were detected in the genes analyzed. This significantly reduces but does not eliminate hereditary cancer risk, as new genes continue to be discovered.
- Variant of Uncertain Significance (VUS): A genetic change was identified whose clinical significance is currently unknown. These results require careful interpretation and may become clearer as more research data becomes available.
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | OncoPro Hereditary Cancer Risk Panel – 200 Gene Screening |
| Discount Price | $820 USD |
| Regular Price | $910 USD |
| Turnaround Time | 35 Working Days |
| Sample Type | 10 mL whole blood in Lavender Top (EDTA) tube |
| Methodology | Next Generation Sequencing |
Sample Collection and Preparation
Proper sample handling is crucial for accurate results. Our testing requires 10 mL (8 mL minimum) of whole blood collected in a Lavender Top EDTA tube. Samples must be shipped immediately at 18-22°C and should never be refrigerated or frozen. The mandatory Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27) must be completed and submitted with your sample.
Nationwide Accessibility
We have conveniently located branches across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services for patients nationwide.
Take Control of Your Cancer Risk Today
Don’t leave your health to chance. Understanding your genetic cancer risk is one of the most powerful steps you can take toward proactive health management. Our experienced genetic counselors are available to discuss your results and provide personalized recommendations based on your genetic profile.
Ready to schedule your OncoPro Hereditary Cancer Risk Panel? Call our dedicated genetics team at +1(267) 388-9828 or book your appointment online. Take the first step toward personalized cancer prevention and early detection strategies today.
